|
| Rural Site 1 n = 51 | Rural Site 2 n = 78 | DTx n = 73 | NDTx n = 56 | All Subjects n = 129 |
| Age in years |
|
|
|
|
|
| Mean (SD) | 63.9 (±10.8) | 65.7 (±10.1) | 66.2 (±9.6) | 63.5 (±11.1) | 65.0 (±10.3) |
| Gender |
|
|
|
|
|
| Number of subjects (proportion) |
|
|
|
|
|
| Male | 28 (55%) | 44 (56%) | 38 (52%) | 34 (61%) | 72 (56%) |
| Female | 23 (45%) | 34 (44%) | 35 (48%) | 22 (39%) | 57 (44%) |
| Primary Cancer treated |
|
|
|
|
|
| number of subjects (proportion) |
|
|
|
|
|
| Bowel | 16 (31%) | 26 (33%) | 22 (30%) | 20 (36%) | 42 (33%) |
| Breast | 6 (12%) | 5 (6%) | 7 (10%) | 4 (7%) | 11 (9%) |
| Cervical/Endometrial/Ovarian | 2 (4%) | 2 (3%) | 2 (3%) | 2 (4%) | 4 (3%) |
| Gastric | 4 (8%) | 4 (5%) | 5 (7%) | 3 (5%) | 8 (6%) |
| Head & Neck | 9 (18%) | 7 (9%) | 13 (18%) | 3 (5%) | 16 (12%) |
| Liver | 3 (6%) | 3 (4%) | 2 (3%) | 4 (7%) | 6 (5%) |
| Lung | 3 (6%) | 12 (15%) | 8 (11%) | 7 (13%) | 15 (12%) |
| Lymphoma/Myeloma | 3 (6%) | 16 (21%) | 10 (13%) | 9 (16%) | 19 (15%) |
| Prostate | 1 (2%) | 1 (1%) | 2 (3%) | 4 (7%) | 2 (2%) |
| Other† | 4 (8%) | 2 (3%) | 2 (3%) | 4 (7%) | 6 (5%) |